ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell... ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.38 | 20 | 1.9 | 2.44 | 1.73 | 363330 | 2.08153266 | CS |
4 | -0.12 | -5 | 2.4 | 2.52 | 1.58 | 445474 | 2.17427024 | CS |
12 | -1.4 | -38.0434782609 | 3.68 | 4.3499 | 1.58 | 728858 | 2.74855182 | CS |
26 | 1.08 | 90 | 1.2 | 4.44 | 1.2 | 757723 | 2.47611337 | CS |
52 | -10.64 | -82.3529411765 | 12.92 | 12.92 | 1.12 | 759740 | 2.61168727 | CS |
156 | -7.12 | -75.7446808511 | 9.4 | 14.19 | 1.12 | 453319 | 4.21634708 | CS |
260 | -7.12 | -75.7446808511 | 9.4 | 14.19 | 1.12 | 453319 | 4.21634708 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.